Altus Wealth Group’s Usana Health Sciences USNA Stock Holding History

Altus Wealth Group’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-400	Closed	-$31K	–	733
2020 Q4	$31K	Buy	+400	New	+$30.9K	0.03%	294

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Altus Wealth Group's USNA Position: Q1 2021 in Review

Altus Wealth Group sold out of Usana Health Sciences (USNA) in Q1 2021, closing a stake of 400 shares — an estimated $31K sold.

Altus Wealth Group first reported a position in USNA in Q4 2020 and held it in 1 quarter. The position peaked at $31K in Q4 2020. 198 funds tracked by Wall St. Rank hold USNA as of Q1 2021.

Altus Wealth Group reported no remaining Usana Health Sciences position as of Q1 2021 after selling out during the quarter.
Altus Wealth Group sold 400 Usana Health Sciences shares in Q1 2021, an estimated $31K.
Altus Wealth Group first reported a position in Usana Health Sciences in Q4 2020 and held it in 1 quarter.
Altus Wealth Group's Usana Health Sciences position peaked at $31K in Q4 2020.
198 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2021.

Based on Altus Wealth Group's 13F filing for Q1 2021, filed 14 May 2021.